What's Happening?
The Marfan Foundation and its VEDS Movement division are maintaining their long-standing commitment to advancing research into Vascular Ehlers-Danlos Syndrome (VEDS). This includes supporting both VEDS-specific studies and broader research that could
benefit individuals with the condition. The Foundation has provided significant grants, such as a $100,000 award in 2018 to Harry C. “Hal” Dietz, MD, of Johns Hopkins School of Medicine, for investigating genetic factors in aortic dissection related to VEDS. Another $100,000 award was given in 2020 to David Shreiber, PhD, of Rutgers University, to study collagen III mutations associated with VEDS. Additionally, two current projects, led by Alexander Bashore, PhD, of the Icahn School of Medicine at Mount Sinai (2024 award), and Dar Weiss, PhD, of the University of Denver (2025 award), have each received $100,000, two-year Career Development Awards, with potential benefits for VEDS research. Since 2003, Dr. Dietz’s laboratory has also received $250,000 annually through a major donor commitment, supporting various research projects, including those related to VEDS.
Why It's Important?
This sustained funding and research focus by The Marfan Foundation are crucial for improving the lives of individuals affected by VEDS. VEDS is a serious genetic disorder that can lead to life-threatening complications, particularly aortic dissection. By investing in research, the Foundation aims to enhance scientific understanding of the condition, which can lead to better diagnostic tools, more effective treatments, and ultimately, improved patient outcomes. The grants to researchers like Dr. Dietz, Dr. Shreiber, Dr. Bashore, and Dr. Weiss are vital for exploring genetic factors, collagen mutations, and other aspects of VEDS. This work directly impacts the U.S. healthcare system by potentially reducing the burden of VEDS-related complications, improving quality of life for patients, and offering hope to families grappling with this rare disease. The ongoing commitment also encourages new scientific talent to enter the field, fostering innovation in medical research.
What's Next?
The Marfan Foundation continues to actively solicit high-quality research proposals specifically focused on VEDS. A newly established funding opportunity, the Isabella Noelani Parson Welch Memorial Grant for VEDS Research, offers up to $125,000 over two years to support innovative research. This grant encourages basic, translational, or clinical research addressing any aspect of VEDS, with a focus on accelerating discoveries that can improve diagnosis, management, and patient outcomes. Researchers are encouraged to explore innovative approaches with the potential for significant impact. The VEDS Movement's mission remains centered on saving lives and enhancing the quality of life for individuals with Vascular Ehlers-Danlos Syndrome, indicating a continued push for scientific advancements and patient support.
Beyond the Headlines
The sustained commitment to VEDS research by The Marfan Foundation highlights the critical role of non-profit organizations in addressing rare diseases. Often, conditions like VEDS receive less attention and funding from larger research bodies due to their lower prevalence. The Foundation's efforts not only fill this gap but also create a dedicated ecosystem for VEDS research, fostering collaboration among scientists and driving progress that might otherwise be delayed. This model of targeted funding by disease-specific foundations is essential for advancing medical knowledge and developing therapies for conditions that affect smaller populations. The emphasis on both specific VEDS research and broader studies with potential VEDS benefits demonstrates a comprehensive approach to understanding and combating the disease, reflecting a long-term vision for patient care and scientific discovery.
